CTNM
CTNM
NASDAQ · Pharmaceuticals

Contineum Therapeutics Inc-A

Small-Cap Stocks Pharmaceutical Stocks Healthcare Stocks
$13.53
+0.32 (+2.42%)
As of Sep 20, 10:25 PM ET ·
Analyst Consensus
Strong Buy
14
Analysts
Moderate
Coverage
Buy 12 86%
Hold 2 14%
Sell 0 0%
Price Target
Analyst Price Target +186.9% upside
Low Target $27.95
Average Target $38.82
High Target $46.43
Current Price $13.53
Current
$13.53
Target
$38.82
$27.95 $38.82 avg $46.43
Scenario Analysis
Bear Case
$27.95
106.6%
Low target
Base Case
$38.82
+186.9%
Avg target
Bull Case
$46.43
+243.2%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$17.79
-23.9% from high
52-Week Low
$8.60
+57.3% from low
Target vs 52W High
$38.82
+118.3% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
 Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
 Strong Sell 45 31% — +0.0%
JNJ
Johnson & Johnson
 Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
 Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
 Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
 Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
 Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
 Hold 24 50% $209.87 +194.2%